Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.33 |
| ▸ | RAC2 | P15153 | 1/20 | 0.31 |
| ▸ | RAC3 | P60763 | 1/20 | 0.31 |
| ▸ | CDC42 | P60953 | 1/20 | 0.31 |
| ▸ | RAC1 | P63000 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22893872 | 0.97 | PGR (0.33) | PGRPLA2G2APLA2G4ARAC2RAC3 | |
| SCHEMBL22893781 | 0.97 | PGR (0.34) | PGRPLA2G2APLA2G4ACASP3SENP7 | |
| SCHEMBL22893870 | 0.92 | L3MBTL1 (0.38) | PGRPLA2G2APLA2G4ACASP3SENP7 | |
| SCHEMBL22893994 | 0.91 | ABCG2 (0.33) | — | |
| SCHEMBL22894172 | 0.90 | ABCG2 (0.36) | RAC2RAC3CDC42RAC1 | |
| SCHEMBL24216513 | 0.90 | PLA2G2A (0.36) | PGRPLA2G2APLA2G4ARAC2RAC3 | |
| SCHEMBL22893782 | 0.90 | SIRT2 (0.34) | PGR | |
| SCHEMBL22893792 | 0.89 | ABCG2 (0.36) | RAC2RAC3CDC42RAC1 | |
| SCHEMBL22894085 | 0.89 | ALDH1A1 (0.33) | PGRPLA2G2APLA2G4A | |
| SCHEMBL10059283 | 0.89 | CHEK2 (0.36) | PGRPLA2G2APLA2G4ARAC2RAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210013411-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210013411-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | PGR 1594/4885PLA2G2A 4090/4885PLA2G4A 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.